Logo
DCA

Haleon plc

ftse100
HLN.LHealthcareDrug Manufacturers - Specialty & Generic
£320.90
-1.81%
Last Price
£320.90
2026-06-02
24h Change
-1.81%
-5.90 GBp
Volume
22M
Shares Traded
Data Reliability
Medium
978 points (4 years)

Price History

Start a simulation with this asset

HLN.L

Global parameters

Available data from 7/18/2022 to 6/2/2026

Fundamental Analysis

New
CAGR (5y)
0.53%
Revenue Growth
Net Margin
15.11%
Profitability
ROE
10.15%
Return on Equity
Debt / EBITDA
3.00
Solvency
PEG Ratio
2.42
Valuation vs Growth
Rev. Growth (TTM)
0.60%
Current Trend
Technical focus
HLN.L
30d volatility
21.59%
Distance to MA50
-8.38%
Distance to MA200
-11.49%
Distance to ATH
-22.71%
Momentum 3M
-19.75%
Risk score
N/A

Volatility moderate. Momentum neutral.

About Haleon plc

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company offers oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, and Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands. It also provides various over-the-counter products comprising nasal drops, and cold, flu, and allergy relief products under Theraflu, and Flonase brands for respiratory issues; and pain relief products under Voltaren, Panadol, and Advil brands; and antacids and antihistamine products under TUMS, ENO, and Fenistil brands for digestive health and other issues. Haleon plc was formerly known as DRVW 2022 plc and changed its name to Haleon plc in February 2022. The company was founded in 1715 and is headquartered in Weybridge, the United Kingdom.

Invest in this asset
Buy on Saxo Bank
🏦Regulated Broker
🌍Global Markets Access
📈Pro Tools

Ad link. Capital at risk.

Technical Analysis & Risk

Key Metrics

CAGR1.03%
Volatility21.59%
Max Drawdown-22.71%

Momentum : HLN.L

Indicateur synthétique
PEURNEUTREAVIDITÉ
45
Neutral

Risk Analysis

VaR (95%)-2.09%
DCA Health
95/100

Recent History (60 days)

DateCloseVolume
2026-06-02£320.9021,951,185
2026-06-01£326.8021,693,011
2026-05-29£336.7039,828,100
2026-05-28£341.6012,510,163
2026-05-27£346.7013,784,600
2026-05-26£341.9015,283,709
2026-05-22£343.8014,662,054
2026-05-21£342.3012,833,173
2026-05-20£341.2026,045,162
2026-05-19£342.3032,264,179
2026-05-18£337.103,343
2026-05-15£332.9023,060,820
2026-05-14£329.1012,006,424
2026-05-13£329.8021,958,648
2026-05-12£335.0026,249,110
2026-05-11£327.1026,589,198
2026-05-08£331.2039,710,825
2026-05-07£335.1024,705,525
2026-05-06£334.7024,477,098
2026-05-05£334.0025,071,628
2026-05-01£344.109,291,718
2026-04-30£340.0033,780,454
2026-04-29£340.0042,625,743
2026-04-28£350.8022,937,620
2026-04-27£350.3029,013,436
2026-04-24£355.2016,612,014
2026-04-23£351.6031,858,387
2026-04-22£345.9035,330,085
2026-04-21£352.3014,801,298
2026-04-20£356.0014,038,896
2026-04-17£358.6028,514,211
2026-04-16£352.5011,434,902
2026-04-15£353.1023,282,202
2026-04-14£357.2020,374,649
2026-04-13£360.5039,782,540
2026-04-10£364.1011,671,081
2026-04-09£364.4016,251,171
2026-04-08£368.9023,398,498
2026-04-07£369.2011,092,321
2026-04-02£372.9012,418,059
2026-04-01£371.5022,275,259
2026-03-31£373.8021,208,710
2026-03-30£376.2018,566,030
2026-03-27£366.9029,810,656
2026-03-26£365.0016,894,695
2026-03-25£361.9019,429,979
2026-03-24£359.1031,855,821
2026-03-23£365.6015,296,433
2026-03-20£375.7033,890,615
2026-03-19£379.2013,023,597
2026-03-18£386.2016,319,323
2026-03-17£395.0021,323,355
2026-03-16£385.7025,742,500
2026-03-13£374.8021,407,539
2026-03-12£373.0019,701,526
2026-03-11£366.3020,445,386
2026-03-10£373.0039,730,857
2026-03-09£373.9027,864,921
2026-03-06£377.0020,246,597
2026-03-05£381.2027,971,443

Recent Dividends

DateAmount
2026-04-09+£4.90
2025-08-14+£2.20
2025-04-24+£4.60
2024-08-15+£2.00
2024-03-14+£4.20
2023-08-24+£1.80
2023-03-16+£2.40

Related Assets